143 related articles for article (PubMed ID: 37098297)
1. Structure-activity relationship study of RSL3-based GPX4 degraders and its potential noncovalent optimization.
Zheng C; Wang C; Sun D; Wang H; Li B; Liu G; Liu Z; Zhang L; Xu P
Eur J Med Chem; 2023 Jul; 255():115393. PubMed ID: 37098297
[TBL] [Abstract][Full Text] [Related]
2. A potent GPX4 degrader to induce ferroptosis in HT1080 cells.
Song H; Liang J; Guo Y; Liu Y; Sa K; Yan G; Xu W; Xu W; Chen L; Li H
Eur J Med Chem; 2024 Feb; 265():116110. PubMed ID: 38194774
[TBL] [Abstract][Full Text] [Related]
3. Dual degradation mechanism of GPX4 degrader in induction of ferroptosis exerting anti-resistant tumor effect.
Wang C; Zheng C; Wang H; Shui S; Jin H; Liu G; Xu F; Liu Z; Zhang L; Sun D; Xu P
Eur J Med Chem; 2023 Feb; 247():115072. PubMed ID: 36603510
[TBL] [Abstract][Full Text] [Related]
4. Discovery of ML210-Based glutathione peroxidase 4 (GPX4) degrader inducing ferroptosis of human cancer cells.
Wang H; Wang C; Li B; Zheng C; Liu G; Liu Z; Zhang L; Xu P
Eur J Med Chem; 2023 Jun; 254():115343. PubMed ID: 37087895
[TBL] [Abstract][Full Text] [Related]
5. Design and synthesis of proteolysis-targeting chimeras (PROTACs) as degraders of glutathione peroxidase 4.
Cai M; Ma F; Hu C; Li H; Cao F; Li Y; Dong J; Qin JJ
Bioorg Med Chem; 2023 Jul; 90():117352. PubMed ID: 37257255
[TBL] [Abstract][Full Text] [Related]
6. Ugi reaction-assisted assembly of covalent PROTACs against glutathione peroxidase 4.
Zhu L; Hu S; Yan X; Zeng Q; Zhang B; Jiang L; Yao SQ; Ge J
Bioorg Chem; 2023 May; 134():106461. PubMed ID: 36924654
[TBL] [Abstract][Full Text] [Related]
7. Design, Synthesis, and Biological Evaluation of Hydrophobic-Tagged Glutathione Peroxidase 4 (GPX4) Degraders.
Li X; Hu M; Zhang Y; Hua H; Sun Y; Xiang Q; Zhu D
Bioorg Chem; 2024 Mar; 144():107115. PubMed ID: 38232684
[TBL] [Abstract][Full Text] [Related]
8. Intracellular Delivery of Glutathione Peroxidase Degrader Induces Ferroptosis In Vivo.
Luo T; Zheng Q; Shao L; Ma T; Mao L; Wang M
Angew Chem Int Ed Engl; 2022 Sep; 61(39):e202206277. PubMed ID: 35924720
[TBL] [Abstract][Full Text] [Related]
9. The ferroptosis inducing compounds RSL3 and ML162 are not direct inhibitors of GPX4 but of TXNRD1.
Cheff DM; Huang C; Scholzen KC; Gencheva R; Ronzetti MH; Cheng Q; Hall MD; Arnér ESJ
Redox Biol; 2023 Jun; 62():102703. PubMed ID: 37087975
[TBL] [Abstract][Full Text] [Related]
10. Lipid Peroxidation-Dependent Cell Death Regulated by GPx4 and Ferroptosis.
Imai H; Matsuoka M; Kumagai T; Sakamoto T; Koumura T
Curr Top Microbiol Immunol; 2017; 403():143-170. PubMed ID: 28204974
[TBL] [Abstract][Full Text] [Related]
11. GPX4 at the Crossroads of Lipid Homeostasis and Ferroptosis.
Forcina GC; Dixon SJ
Proteomics; 2019 Sep; 19(18):e1800311. PubMed ID: 30888116
[TBL] [Abstract][Full Text] [Related]
12. Inactivation of the glutathione peroxidase GPx4 by the ferroptosis-inducing molecule RSL3 requires the adaptor protein 14-3-3ε.
Vučković AM; Bosello Travain V; Bordin L; Cozza G; Miotto G; Rossetto M; Toppo S; Venerando R; Zaccarin M; Maiorino M; Ursini F; Roveri A
FEBS Lett; 2020 Feb; 594(4):611-624. PubMed ID: 31581313
[TBL] [Abstract][Full Text] [Related]
13. Prospects for Anti-Tumor Mechanism and Potential Clinical Application Based on Glutathione Peroxidase 4 Mediated Ferroptosis.
Chen M; Shi Z; Sun Y; Ning H; Gu X; Zhang L
Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36675129
[TBL] [Abstract][Full Text] [Related]
14. GPX4: The hub of lipid oxidation, ferroptosis, disease and treatment.
Liu Y; Wan Y; Jiang Y; Zhang L; Cheng W
Biochim Biophys Acta Rev Cancer; 2023 May; 1878(3):188890. PubMed ID: 37001616
[TBL] [Abstract][Full Text] [Related]
15. Discovery of Novel Potent Covalent Glutathione Peroxidase 4 Inhibitors as Highly Selective Ferroptosis Inducers for the Treatment of Triple-Negative Breast Cancer.
Chen T; Leng J; Tan J; Zhao Y; Xie S; Zhao S; Yan X; Zhu L; Luo J; Kong L; Yin Y
J Med Chem; 2023 Jul; 66(14):10036-10059. PubMed ID: 37452764
[TBL] [Abstract][Full Text] [Related]
16. Discovery and optimization of indirubin derivatives as novel ferroptosis inducers for the treatment of colon cancer.
Zhu JM; Chen C; Kong M; Zhu L; Li YL; Zhang JF; Yu ZP; Xu SS; Kong LY; Luo JG
Eur J Med Chem; 2023 Dec; 261():115829. PubMed ID: 37801824
[TBL] [Abstract][Full Text] [Related]
17. Potent nanoreactor-mediated ferroptosis-based strategy for the reversal of cancer chemoresistance to Sorafenib.
Wang X; Zhao L; Wang C; Wang L; Wu H; Song X; Wang W; Xu H; Dong X
Acta Biomater; 2023 Mar; 159():237-246. PubMed ID: 36736851
[TBL] [Abstract][Full Text] [Related]
18. A white paper on Phospholipid Hydroperoxide Glutathione Peroxidase (GPx4) forty years later.
Ursini F; Bosello Travain V; Cozza G; Miotto G; Roveri A; Toppo S; Maiorino M
Free Radic Biol Med; 2022 Aug; 188():117-133. PubMed ID: 35718302
[TBL] [Abstract][Full Text] [Related]
19. Mitochondrial rescue prevents glutathione peroxidase-dependent ferroptosis.
Jelinek A; Heyder L; Daude M; Plessner M; Krippner S; Grosse R; Diederich WE; Culmsee C
Free Radic Biol Med; 2018 Mar; 117():45-57. PubMed ID: 29378335
[TBL] [Abstract][Full Text] [Related]
20. Cysteine and homocysteine can be exploited by GPX4 in ferroptosis inhibition independent of GSH synthesis.
Xia C; Xing X; Zhang W; Wang Y; Jin X; Wang Y; Tian M; Ba X; Hao F
Redox Biol; 2024 Feb; 69():102999. PubMed ID: 38150992
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]